Research Paper Volume 15, Issue 12 pp 5673—5697
DUSP10 is a novel immune-related biomarker connected with survival and cellular proliferation in lower-grade glioma
Figure 6. Different responses to immunotherapy/chemotherapy of the two subgroups in the TCGA dataset. (A) Differential TIDE scores in the two subtypes. (B, C) Distinct proportions of non-responders and responders to immunotherapy between the two subgroups. (D) Prediction of response to chemotherapeutics drugs in different subtypes.